| George Mitchell Poole, RPH | |
|
2300 Mcfarland Blvd, Suite 5, Northport, AL 35476-2927 | |
| (205) 339-2700 | |
| (205) 330-0920 |
| Full Name | George Mitchell Poole |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 2300 Mcfarland Blvd, Northport, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811286313 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 11216 (Alabama) | Primary |
| 183500000X | Pharmacist | E07653 (Mississippi) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| George Mitchell Poole, RPH 6228 Eastbrook Dr, Tuscaloosa, AL 35405-5668 Ph: (205) 553-9220 | George Mitchell Poole, RPH 2300 Mcfarland Blvd, Suite 5, Northport, AL 35476-2927 Ph: (205) 339-2700 |
News Archive
Emphasizing its commitment to low-dose medical imaging, GE Healthcare today announced 510(k) clearance of its revolutionary Computed Tomography (CT) technology, called Veo,* which may help physicians deliver accurate diagnoses by enabling profound CT image clarity at dramatically lower dose. Veo represents the CT industry's first Model-based Iterative Reconstruction (MBIR) technique, and is already available on GE Discovery CT750 HD systems in Europe, Canada and regions of Asia.
A common osteoporosis drug can shield women against the loss of bone mineral density - a side effect of the drug anastrozole which is taken to prevent breast cancer in the IBIS-2 study - according to new data presented at the San Antonio Breast Cancer Symposium.
The most detailed magnetic resonance images ever obtained of a mammalian brain are now available to researchers in a free, online atlas of an ultra-high-resolution mouse brain, thanks to work at the Duke Center for In Vivo Microscopy.
A team of UC Davis investigators has found that a genetic mutation may play an important role in the development of prostate cancer. The mutation of the so-called p53 (or Tp53) gene was previously implicated in late disease progression, but until now has never been shown to act as an initiating factor. The findings may open new avenues for diagnosing and treating the disease.
Anthera Pharmaceuticals, Inc., today announced that it has entered into definitive agreements with certain accredited investors in connection with a private placement, or PIPE, financing transaction pursuant to Section 4(2) of the Securities Act of 1933, as amended, and Regulation D promulgated thereunder.
› Verified 2 days ago
Daniel Lee Webber, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3107 Lurleen B Wallace Blvd, Northport, AL 35476 Phone: 205-333-9343 Fax: 205-333-1544 | |
Dr. Jessica Jo Salvatore, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5710 Mcfarland Blvd, Northport, AL 35476 Phone: 205-333-7873 | |
Nicholas Matthew Witucki, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3107 Lurleen B Wallace Blvd, Northport, AL 35476 Phone: 205-333-9343 | |
Casey Rasinen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3107 Lurleen B Wallace Blvd, Northport, AL 35476 Phone: 205-333-9343 | |
Dr. Zachary Grant Hunt, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3107 Lurleen B Wallace Blvd, Northport, AL 35476 Phone: 205-333-9343 | |
Jann Sides, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1700 Mcfarland Blvd, Northport, AL 35476 Phone: 205-339-0155 Fax: 205-339-1316 | |
Dr. Robert Meaders Bragg, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2300 Mcfarland Blvd, Northport, AL 35476 Phone: 205-339-2700 |